NCT04672434 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04672434
Title	Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Symphogen A/S
Indications	lung adenocarcinoma pancreatic ductal adenocarcinoma colorectal carcinoma gastroesophageal cancer stomach carcinoma peritoneal mesothelioma esophageal carcinoma cholangiocarcinoma malignant pleural mesothelioma head and neck squamous cell carcinoma
Therapies	Sym021 + Sym024 Sym024
Age Groups:	senior \| adult
Covered Countries	USA \| CAN

NCT04672434
Clinical Trial Detail